Date | Insider | Price | Amount |
---|---|---|---|
9-28-2023 Insider Buy |
Pamela Ann Connealy CFO and COO |
$1.87 CAGR » |
$14,960.00 8,000 shares |
9-27-2023 Insider Buy |
Pamela Ann Connealy CFO and COO |
$1.85 CAGR » |
$11,867.54 6,426 shares |
9-27-2023 Insider Buy |
Jitendra Wadhane Chief Accounting Officer |
$1.87 CAGR » |
$4,675.00 2,500 shares |
9-25-2023 Insider Buy |
Pamela Ann Connealy CFO and COO |
$1.67 CAGR » |
$20,043.60 12,000 shares |
9-25-2023 Insider Buy |
Jitendra Wadhane Chief Accounting Officer |
$1.77 CAGR » |
$8,850.00 5,000 shares |
9-22-2023 Insider Buy |
Jitendra Wadhane Chief Accounting Officer |
$1.74 CAGR » |
$4,349.25 2,500 shares |
9-22-2023 Insider Buy |
Pamela Ann Connealy CFO and COO |
$1.74 CAGR » |
$8,695.00 5,000 shares |
3-17-2023 Insider Buy |
Inc Pfizer >10% Owner |
$2.76 CAGR » |
$4,999,999.44 1,811,594 shares |
10-13-2021 Insider Buy |
Mark Chin |
$16.00 CAGR » |
$5,000,000.00 312,500 shares |
10-13-2021 Insider Buy |
Asset Management, LP Cormorant |
$16.00 CAGR » |
$7,200,000.00 450,000 shares |
Also See: Institutional Holders of PYXS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 09/29/2023 | |
End date: | 04/29/2024 | |
Start price/share: | $1.99 | |
End price/share: | $4.44 | |
Dividends collected/share: | $0.00 | |
Total return: | 123.12% | |
Annualized Gain: | 210.97% | |
Starting investment: | $10,000.00 | |
Ending investment: | $22,312.00 | |
Years: | 0.58 |
Pyxis Oncology Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Pyxis Oncology insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PYXS
Free PYXS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Pyxis Oncology Insider Buying occurred are:
Acasti Pharma Insider Buying |